POLISCOPE
Back to feed
Part ofhealthcare →
HR1082FEDERALin_committee

Shandra Eisenga Human Cell and Tissue Product Safety Act

June 24, 2025

healthcaremedical safetytissue donationfederal regulation

Track this bill to get notified when it advances a stage. One tap to stop, anytime.

Where This Stands

Introduced
Committee
Floor Vote
Passed
Signed

Currently in_committee. The next step in the legislative lifecycle is Floor Vote.

Last action
Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.Jun 24, 2025

Version history

Only one version on file - nothing to compare yet. As later stages (committee substitute, engrossed, enrolled) are captured, the redline appears here.

View official text →

The Frame

What this does

The legislation aims to establish stricter safety standards for biological products, which directly impacts the regulatory requirements for tissue banks and the safety protocols for patients receiving these products.

Who is mentioned in the record

Potentially affected actors named in the source documents. Mention is not a position.

Patients

Patients receiving human cell and tissue products may be subject to new safety standards and oversight protocols established by this legislation.

Tissue banks

Tissue banks would be required to comply with new federal safety regulations regarding the processing and distribution of human cell and tissue products.

What changed

Current stage: in_committee.

What's next

Floor Vote.

Summary

This bill proposes new federal safety requirements for s to improve oversight and patient protection. It has been introduced in the House and referred to the Senate Committee on Health, Education, Labor, and Pensions for review.

Key Facts

You don't have to trust us. Each fact below is taken straight from the official document - click any one to see the exact passage, highlighted in the original.

Frequently Asked Questions

What is the purpose of the Shandra Eisenga Human Cell and Tissue Product Safety Act?
The bill is intended to enhance safety standards and oversight for s used in medical treatments.
What is the current status of the bill?
As of February 6, 2025, the bill has been introduced in the House and referred to the Senate Committee on Health, Education, Labor, and Pensions.

Why It Matters

The legislation aims to establish stricter safety standards for biological products, which directly impacts the regulatory requirements for tissue banks and the safety protocols for patients receiving these products.

News Coverage

No news coverage found yet. Articles are indexed twice daily.

Discoveries

Patterns POLISCOPE noticed across the record. These are observations to investigate, not conclusions.

policy shift70% confidence

Increased focus on tissue safety

The introduction of this act suggests a legislative effort to tighten federal oversight of the human cell and tissue product industry.

Shandra Eisenga Human Cell and Tissue Product Safety Act

Connected Entities

organizationSenate Committee on Health, Education, Labor, and Pensions“The committee currently reviewing the bill.”Map →

Analysis Score

0–100
  • Significance60
    How much this matters to a regular citizen
  • Controversy20
    Intensity of disagreement among stakeholders
  • Entertainment5
    Compellingness for a non-policy-wonk reader
  • Buzz15
    Current news / social attention level

Publisher tools

Share or embed this record

POLISCOPE publisher tools

Share or embed this record